Brontictuzumab
Brontictuzumab
Brontictuzumab (pronounced bron-tic-tu-zu-mab) is a monoclonal antibody designed for the treatment of cancer.
Etymology
The name "Brontictuzumab" is derived from the Greek words "bronte" meaning thunder, "ictus" meaning stroke, and "mab" is an abbreviation for monoclonal antibody.
Definition
Brontictuzumab is a type of monoclonal antibody that is being studied in the treatment of certain types of cancer. It binds to a protein called Notch1, which is found on the surface of some types of cancer cells, and may kill them or stop them from growing.
Related Terms
- Monoclonal antibody: A type of protein made in the laboratory that can bind to substances in the body, including cancer cells.
- Notch1: A protein that in humans is encoded by the NOTCH1 gene. It is involved in the development of many types of cells, and it may also play a role in cancer.
- Cancer: A term for diseases in which abnormal cells divide without control and can invade nearby tissues.
See Also
External links
- Medical encyclopedia article on Brontictuzumab
- Wikipedia's article - Brontictuzumab
This WikiMD article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski